stockrowGE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.
- Revenue
- +7.19%
- EPS
- +40.6%
- Free cash flow
- +64.2%
- Total debt
- −1.90%
Quarter to September 2026, against a year earlier
Follow GEHC
Alert me
GE HealthCare Technologies Inc. 10-Q filed Oct 28, 2026
What changed
Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Jul 29, 2026: 6 added · 3 removed · 45 modified; 29 with only figures updated; 1 moved without change
-
Modified
In the second quarter of 2026, we made a strategic change to our executive leadership and to our segments, combining our Imaging and Advanced Visualization Solutions (“AVS”) businesses into a new operating and reportable segment, Advanced Imaging Solutions (“AIS”). Following this organizational change, GE
HealthCare’s operationsHealthCare has three reportable segments: AIS, Pharmaceutical Diagnostics (“PDx”), and Patient Care Solutions (“PCS”), and we assessed their performance using Segment revenues and Segment EBIT. These segments have been identified based on the nature of the products sold and how the Company manages its operations. Historical segment financial information presented within this report has been recast to conform to the new reportable segment structure. For additional information on our segments, refer to Note 3, “Segment Information.”